Aktuelle Rheumatologie 2022; 47(01): 33-42
DOI: 10.1055/a-1718-2941
Übersichtsarbeit

Technische Alltagshilfen in der Rheumatologie – Was ist sinnvoll, was ist bewiesen, welche Perspektiven gibt es?

Assistive Devices for Activities of Daily Living in Rheumatology
Sara Eileen Meyer
1   Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Hannover, Germany
2   Center for Health Economics Research Hannover, Leibniz Universitat Hannover, Hannover, Germany
,
Juliana Rachel Hoeper
1   Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Hannover, Germany
3   Ergotherapie, m&i Fachklinik Bad Pyrmont, Bad Pyrmont, Germany
,
Jens Buchholz
4   Rheumatologie/Innere Medizin, m&i Fachklinik Bad Pyrmont, Bad Pyrmont, Germany
,
Dirk Meyer-Olson
1   Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Hannover, Germany
4   Rheumatologie/Innere Medizin, m&i Fachklinik Bad Pyrmont, Bad Pyrmont, Germany
› Author Affiliations

Zusammenfassung

Einschränkungen der Alltagsaktivität sind ein relevantes gesundheitliches Problem bei Patienten mit entzündlich-rheumatischen Systemerkrankungen. Technische Alltagshilfen nehmen in der Rehabilitation von diesen Teilhabeeinschränkungen einen hohen Stellenwert ein. Wir erläutern Evidenz für den Einsatz von Alltagshilfen und die neuen Entwicklungen auf diesem Gebiet.

Abstract

Restrictions in activities of daily living are a relevant health problem in patients with systemic inflammatory rheumatic diseases. Technical aids for daily living play an important role in the rehabilitation of these limitations. We describe the evidence for the use of daily living aids and the new developments in the field.



Publication History

Article published online:
10 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Zink A, Albrecht K. How frequent are musculoskeletal diseases in Germany?. Z Rheumatol 2016; 75: 346-353 DOI: 10.1007/s00393-016-0094-2.
  • 2 Albrecht K, Huscher D, Eidner T. et al. Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers. Z Rheumatol 2017; 76: 50-57 DOI: 10.1007/s00393-016-0156-5.
  • 3 Albrecht K, Luque Ramos A, Callhoff J. et al. Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons. Z Rheumatol 2018; 77: 102-112 DOI: 10.1007/s00393-017-0294-4.
  • 4 Koketsu JS. Activities of Daily Living. In: Mc Hugh Pendletonn H, Schultz-Krohn W, Hrsg. Pedretti’s Occupational Therapy: Practice Skills for Physical Dysfunction. 8th Edition AuflSt. Louis, Missouri: 63043Elsvier; 2018
  • 5 [Anonym]. International classification of functioning, disability and health: ICF: World Health Organization; 2001
  • 6 Braun J, Zochling J, Grill E. et al. International classification of functioning, disability and health and its significance for rheumatology. Z Rheumatol 2007; 66: 603-606 608-610 DOI: 10.1007/s00393-007-0188-y.
  • 7 [Anonym]. Occupational Therapy Practice Framework: Domain and Process – Fourth Edition. American Journal of Occupational Therapy 2020; 74 DOI: 10.5014/ajot.2020.74S2001.
  • 8 Mau W, Beyer W, Ehlebracht-Konig I. et al. Treat to participation : Position paper of the German Society for Rheumatology on sustained improvement of functional health of patients with rheumatic and musculoskeletal diseases. Z Rheumatol 2015; 74: 553-557 DOI: 10.1007/s00393-015-1640-z.
  • 9 Björk MA, Thyberg IS, Skogh T. et al. Hand function and activity limitation according to health assessment questionnaire in patients with rheumatoid arthritis and healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA Project). The Journal of rheumatology 2007; 34: 296-302
  • 10 Thyberg I, Hass UA, Nordenskiöld U. et al. Survey of the use and effect of assistive devices in patients with early rheumatoid arthritis: a two-year followup of women and men. Arthritis and rheumatism 2004; 51: 413-421 DOI: 10.1002/art.20410.
  • 11 Thyberg I, Hass UA, Nordenskiöld U. et al. Activity limitation in rheumatoid arthritis correlates with reduced grip force regardless of sex: the Swedish TIRA project. Arthritis and rheumatism 2005; 53: 886-896 DOI: 10.1002/art.21595.
  • 12 Fransen J, Uebelhart D, Stucki G. et al. The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis. Ann Rheum Dis 2002; 61: 225-231 DOI: 10.1136/ard.61.3.225.
  • 13 Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483
  • 14 Fries JF, Spitz P, Kraines RG. et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-145 DOI: 10.1002/art.1780230202.
  • 15 Pincus T, Summey JA, Soraci SA. et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis and rheumatism 1983; 26: 1346-1353 DOI: 10.1002/art.1780261107.
  • 16 Maska L, Anderson J, Michaud K. Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken) 2011; 63: S4-S13 DOI: 10.1002/acr.20620.
  • 17 Lautenschlager J, Mau W, Kohlmann T. et al. Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire. Z Rheumatol 1997; 56: 144-155 DOI: 10.1007/s003930050030.
  • 18 Hammond A, Tyson S, Prior Y. et al. Linguistic validation and cultural adaptation of an English version of the evaluation of daily activity questionnaire in rheumatoid arthritis. Health and quality of life outcomes 2014; 12: 143 DOI: 10.1186/s12955-014-0143-y.
  • 19 Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum 1980; 23: 146-152 DOI: 10.1002/art.1780230203.
  • 20 Hurst NP, Kind P, Ruta D. et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-559 DOI: 10.1093/rheumatology/36.5.551.
  • 21 de Boer IG, Peeters AJ, Ronday HK. et al. Assistive devices: usage in patients with rheumatoid arthritis. Clin Rheumatol 2009; 28: 119-128 DOI: 10.1007/s10067-008-0989-7.
  • 22 Mau W. Ambulante Versorgung von Pantienten mit entzündlich-rheumatischen Krankheiten mit physikalisch-medizinischen Maßnahmen. In: Lange U, Hrsg. Lehrbuch Physikalische Medizin in der Rheumatologie. Bad Nauheim: Rheuma Wissen; 2012
  • 23 Rodrigues M, Rodrigues J, Afonso C. et al. Hand function and adaptive equipment use in patients with rheumatoid arthritis. Acta Reumatol Port 2019; 44: 273-280
  • 24 Li LC, Feehan LM, Xie H. et al. Efficacy of a Physical Activity Counseling Program With Use of a Wearable Tracker in People With Inflammatory Arthritis: A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2020; 72: 1755-1765 DOI: 10.1002/acr.24199.
  • 25 Knitza J, Simon D, Lambrecht A. et al. Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study. JMIR Mhealth Uhealth 2020; 8: e19661 DOI: 10.2196/19661.
  • 26 Cifu DX., Hrsg. Braddom’s Physical Medicine and Rehabilitation. 6. AuflElsevier; 2020. doi:10.1016/C2017-0-03586-3
  • 27 McHugh Pendleton H, Schultz-Krohn W., Hrsg. Pedretti’s Occupational Therapy. 8th EditionElsevier; 2017
  • 28 Hochberg MC, Gravallese EM, Silman AJ. et al. Rheumatology. 2019
  • 29 Torrens GE, Smith NC. Evaluation of an assistive technology product design using a paired comparisons method within a mixed methods approach: a case study evaluating preferences for four types of cutlery with 34 upper limb impaired participants. Disabil Rehabil Assist Technol 2013; 8: 340-347 DOI: 10.3109/17483107.2012.735746.
  • 30 Renda G, Jackson S, Kuys B. et al. The cutlery effect: do designed products for people with disabilities stigmatise them?. Disabil Rehabil Assist Technol 2016; 11: 661-667 DOI: 10.3109/17483107.2015.1042077.
  • 31 Janson R, Burkhart K, Firchau C. et al. Three-dimensional printed assistive devices for addressing occupational performance issues of the hand: A case report. J Hand Ther 2020; 33: 164-169 DOI: 10.1016/j.jht.2020.03.025.
  • 32 Averns H, Hall J, Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. The Journal of rheumatology 1999; 26: 2615-2618
  • 33 Tuntland H, Kjeken I, Nordheim LV. et al. Assistive technology for rheumatoid arthritis. Cochrane Database Syst Rev 2009; DOI: 10.1002/14651858.CD006729.pub2. CD006729 10.1002/14651858.CD006729.pub2
  • 34 Magnol M, Eleonore B, Claire R. et al. Use of eHealth by Patients With Rheumatoid Arthritis: Observational, Cross-sectional, Multicenter Study. J Med Internet Res 2021; 23: e19998 DOI: 10.2196/19998.
  • 35 Amaral DS, Duarte A, Barros SS. et al. Assistive devices: an effective strategy in non-pharmacological treatment for hand osteoarthritis-randomized clinical trial. Rheumatol Int 2018; 38: 343-351 DOI: 10.1007/s00296-017-3892-1.
  • 36 Schneider M, Baseler G, Funken O. et al. Management der fruhen rheumatoiden Arthritis: Interdisziplinare Leitlinie. Z Rheumatol 2020; 79: 1-38 DOI: 10.1007/s00393-020-00775-6.
  • 37 Fernandes L, Hagen KB, Bijlsma JW. et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 2013; 72: 1125-1135 DOI: 10.1136/annrheumdis-2012-202745.
  • 38 Geenen R, Overman CL, Christensen R. et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018; 77: 797-807 DOI: 10.1136/annrheumdis-2017-212662.
  • 39 „vom“. 2016,
  • 40 Frank AO, De Souza LH. Recipients of electric-powered indoor/outdoor wheelchairs provided by a national health service: a cross-sectional study. Arch Phys Med Rehabil 2013; 94: 2403-2409 DOI: 10.1016/j.apmr.2013.07.010.
  • 41 Zhou DJ, Mikuls TR, Schmidt C. et al. Driving Ability and Safety in Rheumatoid Arthritis: A Systematic Review. Arthritis Care Res (Hoboken) 2021; 73: 489-497 DOI: 10.1002/acr.24137.
  • 42 Rekaya N, Vicik SM, Hulesch BT. et al. Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits. Rheumatol Ther 2020; 7: 537-552 DOI: 10.1007/s40744-020-00216-5.
  • 43 Tischer B, Mehl A. Patients’ and nurses’ preferences for autoinjectors for rheumatoid arthritis: results of a European survey. Patient Prefer Adherence 2018; 12: 1413-1424 DOI: 10.2147/PPA.S169339.
  • 44 Thakur K, Biberger A, Handrich A. et al. Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe. Rheumatol Ther 2016; 3: 245-256 DOI: 10.1007/s40744-016-0048-9.
  • 45 van den Bemt BJF, Gettings L, Domanska B. et al. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience. Drug Deliv 2019; 26: 384-392 DOI: 10.1080/10717544.2019.1587043.
  • 46 Rho YH, Rychlewska-Hanczewska A, Sliwowska B. et al. Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis. Adv Ther 2019; 36: 2287-2295 DOI: 10.1007/s12325-019-01027-z.
  • 47 Fettner S, Mela C, Wildenhahn F. et al. Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector. Expert Opin Drug Deliv 2019; 16: 551-561 DOI: 10.1080/17425247.2019.1604678.
  • 48 Domanska B, VanLunen B, Peterson L. et al. Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert Opin Drug Deliv 2017; 14: 15-22 DOI: 10.1080/17425247.2016.1256283.
  • 49 Cohen S, Klimiuk PA, Krahnke T. et al. Successful administration of BI 695501, an adalimumab biosimilar, using an autoinjector (AI): results from a Phase II open-label clinical study (VOLTAIRE((R))-RL). Expert Opin Drug Deliv 2018; 15: 545-548 DOI: 10.1080/17425247.2018.1472572.
  • 50 Schiff M, Koo J, Jin E. et al. Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis. Adv Ther 2016; 33: 199-213 DOI: 10.1007/s12325-016-0286-9.
  • 51 Hallberg D, Salimi N. Qualitative and Quantitative Analysis of Definitions of e-Health and m-Health. hir 2020; 26: 119-128 DOI: 10.4258/hir.2020.26.2.119.
  • 52 WorldHealthOrganization. mHealth. New horizons for health through mobile technologies. Global Observatory for eHealth series 2011; 3
  • 53 WorldHealthOrganization. Fifty-eight world health assembly. eHealth 2005; 108-109
  • 54 Negrini F, de Sire A, Lazzarini SG. et al. Reliability of activity monitors for physical activity assessment in patients with musculoskeletal disorders: A systematic review. J Back Musculoskelet Rehabil 2021; DOI: 10.3233/BMR-200348. doi:10.3233/BMR-200348
  • 55 Davergne T, Rakotozafiarison A, Servy H. et al. Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?. Sensors (Basel) 2020; 20 DOI: 10.3390/s20174797.
  • 56 Seppen BF, den Boer P, Wiegel J. et al. Asynchronous mHealth Interventions in Rheumatoid Arthritis: Systematic Scoping Review. JMIR Mhealth Uhealth 2020; 8: e19260 DOI: 10.2196/19260.
  • 57 Gossec L, Guyard F, Leroy D. et al. Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology. Arthritis Care Res (Hoboken) 2019; 71: 1336-1343 DOI: 10.1002/acr.23768.
  • 58 Najm A, Lempp H, Gossec L. et al. Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study. JMIR Mhealth Uhealth 2020; 8: e14351 DOI: 10.2196/14351.
  • 59 O'Brien CM, Duda JL, Kitas GD. et al. Measurement of sedentary time and physical activity in rheumatoid arthritis: an ActiGraph and activPAL validation study. Rheumatol Int 2020; 40: 1509-1518 DOI: 10.1007/s00296-020-04608-2.
  • 60 Tierney M, Fraser A, Purtill H. et al. Study to determine the criterion validity of the SenseWear Armband as a measure of physical activity in people with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013; 65: 888-895 DOI: 10.1002/acr.21914.
  • 61 Larkin L, Nordgren B, Purtill H. et al. Criterion Validity of the activPAL Activity Monitor for Sedentary and Physical Activity Patterns in People Who Have Rheumatoid Arthritis. Phys Ther 2016; 96: 1093-1101 DOI: 10.2522/ptj.20150281.
  • 62 Espinoza F, Le Blay P, Coulon D. et al. Handgrip strength measured by a dynamometer connected to a smartphone: a new applied health technology solution for the self-assessment of rheumatoid arthritis disease activity. Rheumatology (Oxford) 2016; 55: 897-901 DOI: 10.1093/rheumatology/kew006.
  • 63 Navarro-Millan I, Zinski A, Shurbaji S. et al. Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study. Arthritis Care Res (Hoboken) 2019; 71: 80-87 DOI: 10.1002/acr.23580.
  • 64 Druce KL, Dixon WG, McBeth J. Maximizing Engagement in Mobile Health Studies: Lessons Learned and Future Directions. Rheum Dis Clin North Am 2019; 45: 159-172 DOI: 10.1016/j.rdc.2019.01.004.